alnylam.com
Strategic Alliances – Alnylam
http://www.alnylam.com/our-approach/strategic-alliances
Delivery of RNAi Therapeutics. Hereditary ATTR Amyloidosis with Polyneuropathy (hATTR-PN). Hereditary ATTR Amyloidosis with Cardiomyopathy (hATTR-CM). Access to Investigational Drugs. Free Third-Party Generic Screening and Counseling Programs. Patient Connect E-Mail Alert Sign Up. Access to Investigational Drugs. Delivery of RNAi Therapeutics. Genetic Medicine Strategic Therapeutic Area (STAr). Hereditary ATTR Amyloidosis with Polyneuropathy (hATTR-PN). The venture philanthropy subsidiary of the Alpha-1 ...
inhibrx.com
Alpha-1 Disease - InhibRx
http://inhibrx.com/therapeutic-areas/aat-deficiency
Inhibrx’s AAT-Fc has the potential to benefit Alpha-1 Disease patients through improved efficacy and less frequency dosing. This therapeutic is supported by the Alpha-1 Project and is expected to initiate clinical studies in 2017. Inhibrx’s AAT-Fc therapeutic is manufactured in mammalian cells, the industry standard for commercial therapeutic antibody and Fc fusion protein production. Cell line development data indicate this therapeutic is a high yielding protein that is easily scalable and will have...
imisoftwareinc.com
Web Design Portfolio | DotNetNuke | IMI Software, Inc.
http://www.imisoftwareinc.com/Portfolio.aspx
Learn About Our Author Web Solutions. Learn About Our Author Web Solutions. Have a look at some of our work. In partnership with R2integrated. Benfield Electric, Inc. Telemachus Press, LLC. In partnership with R2integrated. DeThomas and Son Concrete. Sycee Capital, LLC. The Beaver Bat Company. Walt Siefert Real Estate. The COPD Foundation is hosting the COPD8USA Conference June 14-15, 2013 in Chicago, Illinois. The Beaver Bat Company. The Beaver Bat Company. Telemachus Press, LLC. Telemachus Press, LLC.
alnylam.com
Alpha-1 Antitrypsin Deficiency – Alnylam
http://www.alnylam.com/product-pipeline/alpha-1-antitrypsin-deficiency
Delivery of RNAi Therapeutics. Hereditary ATTR Amyloidosis with Polyneuropathy (hATTR-PN). Hereditary ATTR Amyloidosis with Cardiomyopathy (hATTR-CM). Access to Investigational Drugs. Free Third-Party Generic Screening and Counseling Programs. Patient Connect E-Mail Alert Sign Up. Access to Investigational Drugs. Delivery of RNAi Therapeutics. Genetic Medicine Strategic Therapeutic Area (STAr). Hereditary ATTR Amyloidosis with Polyneuropathy (hATTR-PN). In May 2015, we filed a Clinical Trial Application ...